ADMA Biologics Inc Cash Flow-to-Debt Ratio
ADMA Biologics Inc cash flow-to-debt ratio. ADMA Biologics Inc (ADMA) has a Cash Flow-to-Debt Ratio of 0.11x as of June 2026, meaning its operating cash flow of $29.54 Million could theoretically repay 0% of its total liabilities ($276.00 Million) in one year. Check cash flow reinvestment rate of ADMA Biologics Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ADMA Biologics Inc (2006–2025)
Cash flow-to-debt ratio of ADMA Biologics Inc from 2006 to 2025. Historical debt coverage capacity for ADMA Biologics Inc across 20 annual periods. Check ADMA Biologics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
ADMA Biologics Inc Cash Flow-to-Debt Ratio by Year (2006–2025)
ADMA Biologics Inc cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for ADMA Biologics Inc. For the full cash flow conversion analysis, see ADMA cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | $50.40 Million | $146.92 Million | ▼ -59.6% |
| 2024 | 0.85x | $118.67 Million | $139.66 Million | ▲ +1773.0% |
| 2023 | 0.05x | $8.80 Million | $193.98 Million | ▲ +115.0% |
| 2022 | -0.30x | $-59.51 Million | $196.49 Million | ▲ +63.6% |
| 2021 | -0.83x | $-112.37 Million | $135.08 Million | ▲ +2.6% |
| 2020 | -0.85x | $-102.00 Million | $119.42 Million | ▼ -13.1% |
| 2019 | -0.76x | $-76.19 Million | $100.90 Million | ▲ +16.7% |
| 2018 | -0.91x | $-62.68 Million | $69.11 Million | ▼ -64.7% |
| 2017 | -0.55x | $-37.27 Million | $67.69 Million | ▲ +15.2% |
| 2016 | -0.65x | $-18.27 Million | $28.14 Million | ▲ +3.6% |
| 2015 | -0.67x | $-15.42 Million | $22.89 Million | ▲ +2.8% |
| 2014 | -0.69x | $-14.70 Million | $21.22 Million | ▲ +33.8% |
| 2013 | -1.05x | $-10.89 Million | $10.41 Million | ▲ +7.1% |
| 2012 | -1.13x | $-6.90 Million | $6.13 Million | ▲ +79.4% |
| 2011 | -5.47x | $-29.00K | $5.31K | ▼ -243.3% |
| 2010 | -1.59x | $-19.68K | $12.36K | ▲ +43.4% |
| 2009 | -2.82x | $-24.46 Million | $8.69 Million | ▲ +60.8% |
| 2008 | -7.18x | $-19.00 Million | $2.65 Million | ▼ -345.5% |
| 2007 | -1.61x | $-23.61 Million | $14.65 Million | ▲ +0.0% |
| 2006 | -1.61x | $-23.61 Million | $14.65 Million | — |